Ban on growth drug oxytocin comes into effect from July 1 : The Tribune India

Join Whatsapp Channel

Ban on growth drug oxytocin comes into effect from July 1

NEW DELHI:Major curbs on the production and sale of growth hormone oxytocin will come into effect from July 1 with the government determined to end its misuse.



Aditi Tandon

Tribune News Service

New Delhi, June 27

Major curbs on the production and sale of growth hormone oxytocin will come into effect from July 1 with the government determined to end its misuse.

All private manufacturing of oxytocin will end from July 1 and its production for domestic use will be restricted to only one public sector company, Karnataka Antibiotics and Pharmaceuticals Limited (KAPL).

This move follows a previous ban on imports of oxytocin used heavily in enhancing puberty among child victims of sex trafficking, inducing child birth and boosting the growth of vegetables and fruits.

The Health Ministry on Wednesday said: “From July 1, no private manufacturer will be allowed to manufacture the drug for domestic use. Only KAPL, a public sector company, will be manufacturing this drug for domestic use from that date. The oxytocin formulations meant for domestic consumption will be supplied by the KAPL to registered hospitals and clinics in public and private sector directly. Oxytocin in any form or name will not be allowed to be sold through retail chemists.” Registered hospitals that want oxytocin for medical use will need to place orders directly with KAPL.

The ban on oxytocin imports had come into effect on April 27 this year. Earlier in 2014, the Centre banned oxytocin injections but misuse of the hormone continued. Studies have suggested rural health workers in some areas used oxytocin injections to induce child birth among women during home deliveries. Excessive use of oxytocin in cattle by farmers to improve milk production leading to reduction in the animal’s lifespan was also documented. Humans consuming oxytocin-infested milk can suffer hormonal imbalances.

The latest set of bans follow approvals from the Drugs Technical Advisory Board, a statutory body under the Drugs and Cosmetics Act, 1940. New rules say the label of oxytocin formulations produced by KAPL will bear barcodes. The manufacture of oxytocin formulations for export purposes, however, will be open to public and private sector but packs manufactured for exports will also bear barcodes.


A neurotransmitter 

Oxytocin is a neurotransmitter and a hormone produced in the hypothalamus. From there, it is transported to and secreted by the pituitary gland at the base of the brain. It plays a role in the female reproductive functions from sexual activity to childbirth and breast feeding.

Why banned 

The move follows proof of gross misuse of the growth hormone for sexual maturation of child victims of sex trafficking, improvement of milch cattle performance, inducement of child birth and for better appearance of vegetables and fruits.

Top News

Iraq's popular mobilization forces post hit in air strike, sources say

Iraq's popular mobilization forces post hit in air strike, sources say

US official said there had been no US military activity in I...

Indian student's death in US possibly linked to 'Blue Whale Challenge': Report

Indian student's death in US possibly linked to 'Blue Whale Challenge': Report

The 20-year-old, who will remain unnamed here in deference t...

Tesla's Elon Musk postpones India trip, sources say

Tesla's Elon Musk postpones India trip, sources say

Tesla and Modi's office did not immediately respond to reque...

Phase-1 sees 62% turnout; violence mars polling in West Bengal, Manipur

Lok sabha elections 2024: Phase-1 sees 62% turnout; violence mars polling in West Bengal, Manipur

Tripura leads with 80% | Bihar at bottom with 48.5% | Easter...

Man sets self on fire outside New York court where Trump trial under way

Man sets self on fire outside New York court where Trump trial under way

The man burned for several minutes in full view of televisio...


Cities

View All